Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

Todd Neale

September 17, 2021

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Daily News

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

November 21, 2013

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

News Daily News

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

June 05, 2012

Advertisement

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

Reduction in BP Drives Treatment Preference for Hypertensive Patients

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Renal Denervation a Third Option for Hypertension, European Experts Say

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content